🤖 AI Agent Friendly: This page is available in clean token-optimized Markdown.
View as .md

$NEO

Fading Quickly

Snapshot Window: 2026-08-12 20:50 UTC · ← Back to Crypto Overview

Tracked Posts
3
Total Impressions
348
Total Likes
41
Retweets & Quotes
1
Comments
29

Social Momentum Summary

Total Engagement - Comments: 29, Retweets: 1, Likes: 41, Impressions: 348

Verbatim Community Citations & Social Evidence 3 source posts analyzed

@Exx00nes

Yooo 20 GTD SPOTS Follow @skelly_hood and @Exx00nes Gib evm wallet in comment 24 h

A digital artwork showing a penguin wearing a green cap and white robe standing next to a glitchy skeletal figure against a bright yellow-green background with a pink grid floor.

AI visual note: A digital artwork showing a penguin wearing a green cap and white robe standing next to a glitchy skeletal figure against a bright yellow-green background with a pink grid floor.

@Joshuwa

$ALGO v5.0.0 gives node runners a vote. If it passes, accounts get post-quantum support at the protocol level. The upgrade also changes fee pricing and expands what the AVM can handle. Security upgrades matter for networks facing new computing threats at scale.

A blue promotional graphic announces 'Big things are coming to Algorand in v5.0.0,' highlighting features like Larger AVM, Resource-based pricing, and Quantum Accounts, with a call to 'Ready? Upgrade now.'

AI visual note: A blue promotional graphic announces 'Big things are coming to Algorand in v5.0.0,' highlighting features like Larger AVM, Resource-based pricing, and Quantum Accounts, with a call to 'Ready? Upgrade now.'

@NiomeAI

Precision medicine is a $44 billion market, but it still has a data problem. Niome is building a different way to serve that market, with synthetic genomic data generated on Bittensor without relying on identifiable patient genomes. Genomes.io has operated in

The image is a slide titled "Bridging Precision Medicine & Bittensor" from Niome, featuring two sections—pink ("Our Contribution to Precision Medicine") listing privacy-safe genomic data, rare disease research coverage of conditions like heart disease, Alzheimer's, cancer, and schizophrenia, and stronger treatment-response models, and teal ("Our Contribution to Bittensor") highlighting revenue generation, real adoption, and potential token buybacks tied to growth—illustrating how Niome's synthetic genomic data approach connects the $44 billion precision medicine market with decentralized AI on Bittensor.

AI visual note: The image is a slide titled "Bridging Precision Medicine & Bittensor" from Niome, featuring two sections—pink ("Our Contribution to Precision Medicine") listing privacy-safe genomic data, rare disease research coverage of conditions like heart disease, Alzheimer's, cancer, and schizophrenia, and stronger treatment-response models, and teal ("Our Contribution to Bittensor") highlighting revenue generation, real adoption, and potential token buybacks tied to growth—illustrating how Niome's synthetic genomic data approach connects the $44 billion precision medicine market with decentralized AI on Bittensor.

Contributing Voices for $NEO

@xneosolana @xneosol @DD____